- Home
- ALEC vs MTLS Comparison
ALEC vs MTLS Comparison
Compare ALEC & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALEC | MTLS |
|---|---|---|
| Founded | 2013 | 1990 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.2M | 317.9M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ALEC | MTLS |
|---|---|---|
| Price | $2.18 | $5.76 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.83 | N/A |
| AVG Volume (30 Days) | ★ 437.9K | 87.2K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $21,045,000.00 | N/A |
| Revenue This Year | $2.03 | $6.38 |
| Revenue Next Year | $29.87 | $6.45 |
| P/E Ratio | ★ N/A | $61.39 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.01 | $4.78 |
| 52 Week High | $3.40 | $6.80 |
Technical Indicators
Market Signals| Indicator | ALEC | MTLS |
|---|---|---|
| Relative Strength Index (RSI) | 42.98 | 65.22 |
| Support Level | $1.89 | $5.72 |
| Resistance Level | $2.57 | $5.89 |
| Average True Range (ATR) | 0.16 | 0.22 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 24.46 | 98.62 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About MTLS Materialise NV
Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.